Expanded Access to Investigational Medicines

Senti Biosciences, Inc. is a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.

At this time, Senti Biosciences does not provide access to investigational products outside of our IND clinical trials. We encourage patients to participate in clinical trials of our investigational therapies whenever possible, because clinical trials are designed, conducted and monitored to ensure that the safety and efficacy of our products are appropriately evaluated before they are submitted to regulatory agencies for review with the intent to make them more broadly available to patients.

You and your health care provider may learn more about our clinical trials by going to the pipeline section of our website or visiting www.clinicaltrials.gov and searching for Senti Biosciences.

If you are a healthcare provider who is interested in learning more about one of our investigational therapies, or a physician with questions about participation in one of our clinical trials, please submit a request to clinicaltrials@sentibio.com. The company will acknowledge questions as soon as possible, usually within 5 business days of receipt.

If applicable, this website will be updated with hyperlinks to the relevant expanded access information on www.clinicaltrials.gov upon activation. Senti Biosciences reserves the right to revise this expanded access policy at any time.